OpenAlex
PricingAboutJobs
Log inGet started
Work

Differentiating among incretin therapies: a multiple-target approach to type 2 diabetes

HTML

Year: 2012
Type: review
Study design: Systematic Review
Source: Journal of Clinical Pharmacy and Therapeutics
DOI: 10.1111/j.1365-2710.2012.01342.x
Author: S. Cornell
Institution: Midwestern University
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: type 2 diabetes, incretin-based therapy, GLP-1 receptor agonists, DPP-4 inhibitors, liraglutide, exenatide, HbA1c, fasting blood glucose, postprandial blood glucose, weight loss, beta-cell function, hypoglycemia, drug selection, combination therapy, obesity, hypertension, cardiovascular risk, drug safety
SDG: Good health and well-being

Open Access status: closed

Funder: Novo Nordisk
OpenAlex ID: W1919558603
FWCI: 0.761
Cites: 90
Cited by: 42
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security